All that certainly seems possible. And who knows what other pharma or pharma's may be watching and interested if results are good. In this information age, I bet few companies have access to information that other competitors can't get. So who knows? All we can do in the public sphere is speculate and hopefully be in position when the shoe drops. Would IPIX take any first deal offered (Novartis, AS, or some other company) or would the trial results be strong enough for them to choose among offers? I'd be fine with Novartis tomorrow morning because I believe Mr. Ehrlich will ultimately do what is best for all, but I'll wait for what IPIX and LW can develop if that doesn't happen. GLTY